ITMCTR2200005856尚未招募1 期
A prospective, real-world cohort study of Huashi Baidu granule in the treatment of mild or asymptomatic COVID-19
Shuguang Hospital Affiliated to Shanghai University of traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 18 至 60（—）
- 性别
- All
入选标准
- •(1) Age 18-60 years old (including 18 and 60 years old), regardless of gender;
- •(2) nucleic acid test results were positive, including New Coronavirus mild / asymptomatic infection.
- •(3) Voluntarily participate in the experiment and sign the written informed consent.
排除标准
- •(1) Complicated with influenza, other pneumonia, suppurative tonsillitis, acute tracheobronchial inflammation, pulmonary tuberculosis, primary ciliary dyskinesia syndrome, and other acute nasal diseases (such as allergic rhinitis, acute and chronic rhinitis, acute and chronic sinusitis, etc.);
- •(2) During the course of the disease, he has received other oral drugs for the disease before treatment, such as cold drugs, antiviral drugs, antibiotics, traditional Chinese medicine and other drugs;
- •(3) Accompanied by gastrointestinal discomfort symptoms such as acute and chronic diarrhea;
- •(4) merge serious serious diseases such as heart, brain, lung, liver, kidney and blood system, such as viral hepatitis, hemophilia, diabetes mellitus, mental illness, etc.
- •(5) Pregnant or planned pregnant women, lactating women, patients of childbearing age who are unable or unwilling to take adequate contraception during the trial, or their spouses are unwilling to take contraception;
- •(6) Allergic constitution, such as a history of allergy to more than two drugs or foods, or known allergy to various components of the drug in this study;
- •(7) Participate in or are participating in clinical trials of other drugs within 3 months;
- •(8) Those who are unwilling to accept the intervention of traditional Chinese medicine;
- •(9) According to the judgment of the researcher, there are other diseases or conditions that reduce the possibility of enrollment or complicate enrollment, such as pregnancy, frequent changes in working environment, unstable living environment and other conditions that are easy to cause loss of follow-up.
研究者
相似试验
尚未招募
4 期
Retrospective cohort study of Huashi Baidu granules in the treatment of mild COVID-19ovel Coronavirus Pneumonia (COVID-19)ITMCTR2200006037Jiujiang Hospital of Traditional Chinese Medicine
进行中（未招募）
不适用
A clinical study to evaluate HF10 therapy using surgical leadsISRCTN10619673evro Corp339
尚未招募
2 期
Study on Bhoomyamlaki Churna and Chandana Churna in the management of Asrigdara w.s.r to menorrhagia and metrorrhagiaCTRI/2024/08/072148Mansarovar Ayurvedic Medical College Hospital and Research Centre
尚未招募
1 期
A prospective cohort study of Bushenyijing granules Intervention in early-stage Alzheimer's DiseaseAlzheimer's DiseaseITMCTR2000004119Jiangsu Province Hospital of Chinese Medicine
已完成
不适用
Prospective study investigating the incidence of heparin-induced thrombocytopenia in patients treated with mechanical circulatory supportD69.53DRKS00014096niversitätsklinikum Tübingen41